ANTI-FIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS ASSOCIATED WITH SYTEMIC SCLEROSIS: CHARACTERISTICS OF SSC-IAH PATIENTS RECEIVING NINTEDANIB AND ADVERS EVENTS DURING TREATMENT


Creative Commons License

Yalcinkaya Y., Amikishiyev S., Aliyeva N., Artim-Esen B., Gul A., Bingol Z., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.81, ss.1499, 2022 (SCI-Expanded) identifier